Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock
CYCCP
CYCCP
3 hedge funds and large institutions have $100K invested in Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $98K | 13,253 | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | 270 | +270 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $0 | 42 | – | – |
|